Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumor × temsirolimus × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 13 Neoplasm Metastasis 11 Glioblastoma 7 Prostatic Neoplasms 6 Neoplasms 6 Kidney Neoplasms 6 Brain Neoplasms 6 Sarcoma 5 Carcinoma, Hepatocellular 5 Ovarian Neoplasms 4 Glioma 4 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Advanced Cancer 4 Uterine Cervical Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Oligodendroglioma 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Liver Neoplasms 3 Colorectal Neoplasms 3 Astrocytoma 3 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2

Interventions

Fluorodeoxyglucose F18 7 Irinotecan 4 Fluorouracil 4 Bevacizumab 4 pembrolizumab 3 olaparib 3 Radiosurgery 3 Cyclophosphamide 3 Cisplatin 3 Capecitabine 3 vistusertib 2 toripalimab 2 tislelizumab 2 spartalizumab 2 fludarabine 2 atezolizumab 2 apatinib 2 Temozolomide 2 Radiotherapy 2 Proton Therapy 2 Paclitaxel 2 Leucovorin 2 Letrozole 2 Hydroxychloroquine 2 Everolimus 2 Drug Therapy 2 Docetaxel 2 tumor-cells apoptosis factor, human 1 trifluridine tipiracil drug combination 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02446431 2015-05-18

Metronomic

Miller Children's & Women's Hospital Long Beach

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡